Concepedia

Peter Bossuyt

PB

Statistics

Publications

2

Citations

103

H-Index

2

Active since

2021

Affiliations

Imelda Hospital(Current)

Peter Bossuyt is an author at Imelda Hospital specializing in pharmacy, inflammatory bowel disease, and inflammatory bowel disease therapy.

Publications per year

2021–2025

2

Publications

2

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

, , +15

Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study

Geert D’Haens, Mark Löwenberg, Filip Baert et al. · ˜The œLancet. Gastroenterology & hepatology · 2025 · 10 citations · Full text

, , +15

1–2 of 2